Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 6/20 | 1.00 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.68 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.59 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3132594 | 1.00 | SIGMAR1 (1.00) | SIGMAR1TAAR1KCNH2AOC3 | |
| SCHEMBL5721858 | 1.00 | SIGMAR1 (1.00) | SIGMAR1TAAR1KCNH2AOC3 | |
| SCHEMBL9151137 | 1.00 | SIGMAR1 (1.00) | SIGMAR1TAAR1KCNH2AOC3 | |
| SCHEMBL9670745 | 1.00 | SIGMAR1 (1.00) | SIGMAR1TAAR1KCNH2AOC3 | |
| SCHEMBL2117266 | 1.00 | SIGMAR1 (1.00) | SIGMAR1TAAR1KCNH2AOC3 | |
| SCHEMBL8498144 | 1.00 | SIGMAR1 (1.00) | SIGMAR1TAAR1KCNH2AOC3 | |
| SCHEMBL10726207 | 1.00 | SIGMAR1 (1.00) | SIGMAR1TAAR1KCNH2AOC3 | |
| SCHEMBL8079373 | 1.00 | SIGMAR1 (1.00) | SIGMAR1TAAR1KCNH2AOC3 | |
| SCHEMBL22442307 | 1.00 | SIGMAR1 (1.00) | SIGMAR1TAAR1KCNH2AOC3 | |
| SCHEMBL8084103 | 1.00 | SIGMAR1 (1.00) | SIGMAR1TAAR1KCNH2AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 650 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260043148-A1 | CLEANING COMPOSITION WITH MOLYBDENUM ETCHING INHIBITOR | ENTEGRIS INC (US) | 2026-02-12 | — | — | US | claimed |
| EP-4536795-A1 | CLEANING COMPOSITION WITH MOLYBDENUM ETCHING INHIBITOR | Entegris, Inc. (US) | 2025-04-16 | — | — | EP | claimed |
| EP-4048751-B1 | POLISHING COMPOSITION AND METHOD WITH HIGH SELECTIVITY FOR SILICON NITRIDE AND POLYSILICON OVER SILICON OXIDE | CMC MAT LLC (US) | 2025-03-19 | — | — | EP | claimed |
| US-12146089-B2 | Nanostructure ink compositions for inkjet printing | SHOEI CHEMICAL INC. (JP) | 2024-11-19 | — | — | US | claimed |
| EP-4007800-B1 | NANOSTRUCTURE INK COMPOSITIONS FOR INKJET PRINTING | SHOEI CHEMICAL IND CO (JP) | 2024-01-03 | — | — | EP | claimed |
| US-20230399754-A1 | CLEANING COMPOSITION WITH MOLYBDENUM ETCHING INHIBITOR | ENTEGRIS, INC. | 2023-12-14 | — | — | US | claimed |
| WO-2023239837-A1 | CLEANING COMPOSITION WITH MOLYBDENUM ETCHING INHIBITOR | ENTEGRIS, INC. (US) | 2023-12-14 | — | — | WO | claimed |
| US-20230389544-A1 | Food Contact Disinfecting/Sanitizing Formulation And Wipe | Arxada, LLC | 2023-12-07 | — | — | US | claimed |
| US-20230235225-A1 | Nanostructure Ink Compositions for Inkjet Printing | NANOSYS, INC. (US) | 2023-07-27 | — | — | US | claimed |
| US-11555149-B2 | Nanostructure ink compositions for inkjet printing | NANOSYS, INC. (US) | 2023-01-17 | — | — | US | claimed |
| EP-1041115-B1 | Curable resin composition | KANSAI PAINT CO LTD (JP) | 2003-07-09 | — | — | EP | claimed |
| EP-0801948-B1 | Ophthalmic composition having prolonged residence time in the eye | MANN GERHARD CHEM PHARM FAB (DE) | 2001-06-06 | — | — | EP | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| EP-0615858-B1 | Transparent recording sheets | XEROX CORP (US) | 1998-03-25 | — | — | EP | claimed |
| WO-1997038674-A1 | OPHTHALMIC COMPOUND WITH EXTENDED DWELL TIME ON THE EYE | DR. GERHARD MANN CHEMISCH-PHARMAZEUTISCHE FABRIK GMBH (DE) | 1997-10-23 | — | — | WO | claimed |
| EP-0109223-B1 | ELECTROLYTE FOR ZINC-BROMINE STORAGE BATTERIES | KABUSHIKI KAISHA MEIDENSHA MEIDENSHA ELECTRIC MFG. CO., LTD. (JP) | 1987-07-22 | — | — | EP | claimed |
| US-4229227-A | MODIFIED MONTMORILLONITE, NITROCELLULOSE, AND A POLYETHER, OXIDE ADDUCT OR DICARBOXYLIC ESTER AND SOLVENTS | SHISEIDO CO., LTD. (JP) | 1980-10-21 | — | — | US | claimed |
| US-4225498-A | Preparation of N-substituted oligo-imides | RHONE-POULENC INDUSTRIES (FR) | 1980-09-30 | — | — | US | claimed |
| US-4144130-A | PARTITIONING IN A MULTIPHASE SYSTEM | GESELLSCHAFT FUR BIOTECHNOLOGISCHE FORSCHUNG (DE) | 1979-03-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230389544-A1 | Food Contact Disinfecting/Sanitizing Formulation And Wipe | PARG, WIZ, VAC14 | SIGMAR1 3021/4885TAAR1 2588/4885KCNH2 657/4885 |
| US-20260043148-A1 | CLEANING COMPOSITION WITH MOLYBDENUM ETCHING INHIBITOR | PROC, ADH1C, TET2 | SIGMAR1 19/4885TAAR1 788/4885KCNH2 137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.